Semaglutide (SLU)
GLP-1 Receptor Agonist for Weight Management
📲 DM us on Telegram for pricing
Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes that has revolutionized weight management. It works by mimicking the GLP-1 hormone to suppress appetite, slow gastric emptying, and improve metabolic health — leading to significant and sustained fat loss.
Key Benefits
- Significantly reduces appetite and caloric intake
- Promotes substantial fat loss and weight management
- Improves insulin sensitivity and blood sugar control
- Slows gastric emptying for prolonged satiety
- Cardiovascular protective effects
- Supports long-term metabolic health improvements
Recommended Use
Typical starting dose is 0.25mg weekly via subcutaneous injection, titrating up every 4 weeks to a target of 1–2.4mg/week. Consult with a healthcare professional before use.